MedTrace Logo

Call for Life: Exploring mHealth Solutions for Enhancing Childhood Vaccinations Among Displaced Children in Conflict-affected Settings of Nigeria

NCT07154836 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 366

Last updated 2025-09-04

No results posted yet for this study

Summary

This study evaluates the feasibility and preliminary impact of Call for Life, an mHealth platform aimed at increasing childhood vaccination coverage among internally displaced persons in Borno State, Nigeria. The platform uses an interactive voice response (IVR) system to deliver automated vaccination reminders, follow up on reported side effects, and provide health messages in English and local languages. A mixed-methods design is used to assess feasibility, interaction rates, and early effects on vaccine uptake. Findings will inform policymakers and humanitarian actors on the potential of mobile technology to strengthen immunization delivery in conflict-affected, resource-limited settings.

Conditions

  • Access to Immunization

Interventions

OTHER

Telephone calls

Regular telephone reminders and health information will be sent to help mothers or caregivers of children 0-23 months to remind them to go vaccine their children

Sponsors & Collaborators

  • University of Maiduguri

    collaborator OTHER

  • Infectious Disease Institute at Makerere University

    collaborator UNKNOWN

  • University of Cambridge

    lead OTHER

Study Design

Allocation
NA
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
23 Months
Max Age
23 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-06-24
Primary Completion
2025-11-24
Completion
2025-12-30

Countries

  • Nigeria

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07154836 on ClinicalTrials.gov